Imsidolimab Antibody
Imsidolimab (ANB 019) is a humanized monoclonal antibody targeting the IL-36 receptor, blocking IL-36-mediated signaling. It serves as a key research tool for investigating the pathogenesis and treatment of systemic pustular psoriasis in both cellular assays and animal models.
Product Specifications
Product Name Alternative
ANB019, ANB 019
Target
IL Receptor, Interleukin
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
6.92 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
146.71 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog